Woman Has No Evidence to Support LPLA Claims, Manufacturer Says in Motion for Summary Judgment

NEW ORLEANS - A woman who allegedly suffered from diarrhea, abdominal pain and elevated heart rate as a result of using Propulsid cannot provide evidence to support her claims that the manufacturer can be held liable for damages under the Louisiana Products Liability Act (LPLA), the drug maker's motion for summary judgment states. In re: Propulsid Products Liability Litigation, MDL No. 1355 (E.D. La.).

According to the Dec. 17 motion for summary judgment, plaintiff Samantha Reed cannot prove that Propulsid was defective, that the drug had an express warranty, that an alternative design for the drug existed and that the …